|Articles|February 19, 2016

Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach

Author(s)DIA

Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach

A series of contributions emphasizing the increasingly global nature of medical product development and regulation is highlighted in this issue with contributions from around the world. Additional articles on central monitoring, clinical trial outcomes, and data quality are also included.

Trending on PharmExec

Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach

Related Content

Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly

Your Questions Answered: What This Week's Rare Disease and Specialty Drug News Tells Us About Where the Industry Is Heading

Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb

The Shift Towards Globally Sourced Innovation

Why Dealmaking Is Now a Survival Skill: Q&A with Dan Chancellor

Trending on PharmExec

M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration

Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly

When Drug Pricing Becomes Trade Policy

Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb

FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva